Jason M. Frierson U.S. Attorney | U.S. Attorney for the District of Nevada
A Henderson, Nevada man appeared in court on September 10, 2025, to face charges related to the alleged smuggling and distribution of misbranded prescription drugs containing sildenafil and tadalafil. These substances are the active ingredients found in FDA-approved medications Viagra and Cialis. The indictment claims that David Ralph Webber sold these drugs under brand names such as “Kinky Kong,” “Kinky Pink,” “Stif,” “Tbone,” and “Ride” to smoke shops, convenience stores, adult novelty stores, and directly to consumers through his website.
“Americans depend on the FDA to ensure that drugs are safe and accurately labeled,” said FDA Special Agent in Charge Robert M. Iwanicki of the FDA’s Office of Criminal Investigations Los Angeles Field Office. “Today’s announcement illustrates our ongoing emphasis on holding accountable people who circumvent federal regulations and jeopardize public health.”
A federal grand jury indicted Webber on July 30, 2025. He faces one count of introduction of a misbranded drug into interstate commerce, four counts of wholesale distribution of prescription drugs without a license, and seven counts of smuggling.
Court documents allege that Webber owned two Nevada companies: Passion Plus Enterprises Inc. and Whole Science Health. He was not registered with the FDA as a pharmaceutical manufacturer or licensed as a wholesaler or administrator of prescription drugs.
The indictment states that from at least 2018 onward, Webber purchased hundreds of thousands of capsules containing sildenafil and tadalafil from manufacturers in India. After receiving these products, he allegedly distributed them throughout Nevada and the southwestern United States via third-party retailers and direct sales to consumers. Authorities warn that these products can have harmful effects if not administered by a licensed practitioner, especially for individuals taking heart or blood-thinning medications.
Webber is also accused of paying a packaging company to list false ingredients on product labels and make untrue claims that the drugs were “100% Natural” and did not require a prescription. It is alleged many consumers were unaware they were ingesting medicines with the same active ingredients as Viagra or Cialis.
A jury trial is scheduled for November 18, 2025 before United States District Judge Jennifer A. Dorsey.
Acting United States Attorney Sigal Chattah for the District of Nevada and Special Agent in Charge Robert M. Iwanicki announced the case.
The investigation was conducted by the Food and Drug Administration (FDA) along with the United States Postal Inspection Service. Assistant United States Attorney Jean Ripley will prosecute.
Individuals who have taken these products or experienced adverse health effects are encouraged to contact investigators at https://www.accessdata.fda.gov/scripts/email/oc/oci/contact.cfm.
An indictment is an accusation; defendants are presumed innocent unless proven guilty.
